Research and Markets: Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/hcg9kx/ophthalmic) has announced the addition of the "Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report" report to their offering.

“Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report”

This report analyzes the worldwide markets for Opthalmic Pharmaceutical Drugs in US$ million by the following Therapeutic Categories:

- Glaucoma

- Anti-allergy

- Anti-infective

- Dry Eye

- Anti-inflammation

- Back of Eye

- Others.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. A seven-year historic analysis is also provided for these markets.

The report profiles 95 companies including many key and niche players. Market data and analytics are derived from primary and secondary research.

Total Companies Profiled: 95 (including Divisions/Subsidiaries - 126)

Region/Country Players

The United States 49

Canada 4

Japan 8

Europe 39

France 6

Germany 4

The United Kingdom 4

Italy 4

Spain 2

Rest of Europe 19

Asia-Pacific (Excluding Japan) 18

Latin America 1

Middle-East 7

Companies Mentioned Include:

- Acuity Pharmaceuticals, Inc (USA)

- Advanced Medical Optics, Inc (USA)

- Advanced Vision Research, Inc (USA)

- Akorn, Inc (USA)

- Alcon, Inc (USA)

- Alimera Sciences (USA)

- Allergan, Inc (USA)

- Alpharx, Inc (Canada)

- Amoun Pharmaceutical Company SAE (Egypt)

- Aurolab (India)

- Bal Pharma Ltd (India)

- Bausch And Lomb, Inc (USA)

- Bohus Biotech AB (Sweden)

- Cadila Pharmaceuticals Ltd (India)

- Ciron Drugs & Pharmaceuticals (P) Ltd (India)

- Concord Drugs Ltd (India)

- Custom Rx Compounding Pharmacy (USA)

- Cynacon/OCuSOFT (USA)

For more information visit http://www.researchandmarkets.com/research/hcg9kx/ophthalmic